CDKN2C and breast cancer: Consistent with the findings derived from mice, in human breast cancers, loss of p18 and amplification or overexpression of cyclin D and CDK4 are frequently detected in luminal type tumors whereas loss of GATA3 expression and loss or mutation of Rb are key features of BLBCs 8, 27-31.